A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer

NCT04094519 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: enzalutamide
DRUG: enzalutamide Placebo
DRUG: digoxin
DRUG: rosuvastatin

Sponsor

Astellas Pharma Global Development, Inc.

Collaborators

[object Object]